. Correction to: Lenvatinib Targets PDGFR-beta Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights. J Clin Endocrinol Metab 2022 Jul 8. pii: 6633918. doi: 10.1210.
PMID: 35801860